Although the L-enantiomers of amino acids are predominant in living organisms, substantial levels of D-amino To elucidate the overall signaling pathway for D-aspartate in mammals, we have explored the novel site of D-aspartate. Using immunohistochemical approaches involving D-aspartate specific antibodies, we found that the islets of Langerhans, a miniature endocrine organ for blood glucose-regulating hormones, contain D-aspartate.
D-aspartate revealed the localization of the amino acid in a subset of satellite and basket cells in the cerebellum, adrenal chromaffin cells, pituitary glands, Leydig cells and pinealocytes.
2-10) D-Aspartate is believed to modulate neuroendocrine functions in either an intercellular or intracellular manner. In pinealocytes, D-aspartate is synthesized, de novo, localized in the cytoplasm, and released through a Na ϩ -dependent glutamate/aspartate transporter at the plasma membrane. 6, 10) Then, D-aspartate may act as an intercellular messenger and inhibit melatonin synthesis in a receptor-mediated manner.
10) Pheochromocytoma PC12 cells also synthesize Daspartate de novo. 5) Then, PC12 cells store D-aspartate in dopamine-containing secretory granules, and secreted it through exocytosis. 11) In Leydig cells, D-aspartate may act as an intracellular messenger, and stimulate testosterone synthesis through modulation of steroidogenesis. 3, 12) In pituitary cells, internal D-aspartate is metabolically converted to N-methyl-D-aspartate (NMDA). The resultant NMDA in turn stimulates the secretion of hypothalamic releasing hormones. 8) Thus, the modes of action of D-aspartate in neuroendocrine cells seem to be diverse in nature but remains little understood.
To elucidate the overall signaling pathway for D-aspartate in mammals, we have explored the novel site of D-aspartate. Using immunohistochemical approaches involving D-aspartate specific antibodies, we found that the islets of Langerhans, a miniature endocrine organ for blood glucose-regulating hormones, contain D-aspartate.
MATERIALS AND METHODS
Antibodies Antibodies against D-aspartate were prepared according to Schell et al. as described. 2, 6, 11) The antiserum was further purified by affinity chromatography on CNBr-activated Sepharose 4B conjugated with D-aspartate. The purified antibodies were divided into small portions and frozen at Ϫ80°C.
11) The specificity of the purified antibodies was examined by enzyme-linked immunosolvent assay. The antibodies did not cross react with L-aspartate or L-glutamate, or other related amino acids, the details being given previously.
11) Monoclonal antibodies against glucagons, insulin, somatostatin and pancreatic polypeptide were obtained from Sigma, Cymbus Biotechnology Ltd., Chemicon, and Linco Research, respectively.
Immunohistochemical Analysis Immunohistochemical analysis was performed as described 11, 13) with a slight modification. Male Wistar rats were used at 7 postnatal weeks in the study. Rats were anesthetized with ether and then perfused intracardially with saline, followed by 0.2% picric acid and 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Then, their both pancreases and pineal glands were isolated, and then the frozen sections were prepared.
13) Specimens were incubated in phosphate-buffered saline containing bovine serum albumin at 1% and goat serum at 2% containing 0.2% saponin to permeabilize the cellular and organelle membranes for 15 min. Then, specimens were reacted with antibodies at 0.7 mg/ml diluted in phosphate-buffered saline containing 0.5% bovine serum albumin for 1 h at room temperature. Specimens were washed four times with phosphatebuffered saline and then reacted with the second antibodies for 1 h at room temperature, and washed seven times with phosphate-buffered saline. The second antibodies used were Alexa Fluor 568-labeled anti-mouse IgG at 2 mg/ml, Alexa Fluor488-labeled anti-rabbit IgG at 4 mg/ml, FluoroLink Cy3-labeled goat anti-rat IgG at 0.5 mg/ml, FluoroLink Cy3-labeled goat anti-rabbit IgG at 2 mg/ml, or FluoroLink FITClabeled goat anti-guinea pig IgG at 10 mg/ml. These second antibodies were obtained from Molecular Probes. Finally, immunoreactivity was examined under either an Olympus FV300 confocal laser microscope or an Olympus BH-2 fluorescence microscope.
RESULTS AND DISCUSSION
Using immunohistochemical approaches, we have examined novel D-aspartate-containing neuroendocrine cells. We found that significant immunoreactivity is present in the islets of Langerhans (Fig. 1A) . D-Aspartate immunoreactivity is predominantly present in the peripheral region. Weak signals were obtained in the mantle region of the islets. The exocrine part of the pancreas exhibits only a background level of D-aspartate immunoreactivity (Fig. 1A) . The immunoreactivity was not observed when preabsorbed antibodies were used (Fig. 1B) . The D-aspartate immunoreactivity in the pineal gland was also shown, as a positive control (Figs. 1C, D) Islets of Langerhans constitute at least four major types of endocrine cells, glucagon-secreting a cells, insulin-secreting b cells, somatostatin-secreting d cells and pancreatic polypeptide-secreting F cells. Double-labeling immunohistochemistry revealed that D-aspartate immunoreactivity is associated with glucagon, but less with insulin or somatostatin ( Figs. 2A-C) . D-Aspartate immunoreactivity is also partly associated with pancreatic polypeptides (Fig. 2D) . These results indicated that D-aspartate is predominantly present in a cells and a subpopulation of F cells.
Recent increasing evidence shows that excitatory amino acids are involved in the regulation of hormonal secretion in islets [reviewed in ref . 14] . Islets of Langerhans use L-glutamate as a primary intercellular messenger to regulate the secretion of glucagon, followed by regulation of blood glucose [13] [14] [15] [16] : L-glutamate is stored in glucagon-containing secretory granules in a cells, and co-secreted with glucagon upon low glucose stimulation. L-Glutamate is also present in pancreatic polypeptide-containing secretory granules in a subpolulation of F cells. 13, 17) Then, the released L-glutamate 1252 Vol. 29, No. 6 binds to ionotropic glutamate receptors on neighboring b and d cells, causing the secretion of g-aminobutylate and somatostatin, respectively. 15, 16) g-Aminobutylate (GABA) and somatostatin act as secondary intercellular transmitters in islets, and inhibit glucagon secretion in a receptor-mediated manner. 13, 15) a cells also receive L-glutamate signals by way of a metabotropic glutamate receptor, which causes inhibition of glucagon secretion. 16) In the present study, we have shown that that a cells and a subpolulation of F-cells contain D-aspartate (Fig. 2) . Since D-aspartate is excitatory in nature, it is possible that D-aspartate is also involved in L-glutamatemediated intercellular-or intracellular signaling pathway in islets. It is interesting to examine whether a cells secrete D-aspartate, and whether endogenous D-aspartate inhibits glucagons secretion as in the case with L-glutamate. Such studies are currently under way in our laboratory.
